NASDAQ: GNPX - Genprex, Inc.

Yield per half year: -25.05%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Genprex, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Genprex, Inc.

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-03-29
ISIN US3724461047
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.genprex.com
Цена ао 0.38
Change price per day: -20.73% (0.342)
Change price per week: -24.19% (0.3576)
Change price per month: -28.66% (0.38)
Change price per 3 month: -69.03% (0.8753)
Change price per half year: -25.05% (0.3617)
Change price per year: -90.9% (2.98)
Change price per 3 year: -88.56% (2.37)
Change price per 5 year: -94.32% (4.77)
Change price per year to date: -73.42% (1.02)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.56 8
P/E 0 0
EV/EBITDA -0.1567 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -289.21 0
ROE, % -416.11 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 193.02 10
Yield EPS, % 3302.65 10
Total: 8
More

Institutions Volume Share, %
Vanguard Group Inc 45665 2.39
Advisory Services Network, LLC 17185 0.9
CVI Holdings, LLC 15456 0.81
Geode Capital Management, LLC 12321 0.64
Blackrock Inc. 11392 0.6
Renaissance Technologies, LLC 8988 0.47
Citadel Advisors Llc 4780 0.25
State Street Corporation 4311 0.23
Squarepoint Ops LLC 2945 0.15
Commonwealth Equity Services, LLC 2683 0.14



Head Job title Payment Year of birth
Mr. David M. Schloss Senior Vice President of Human Resources N/A
Mr. Thomas C. Gallagher Esq. Senior Vice President of Intellectual Property & Licensing N/A
Dr. Mark S. Berger M.D. Chief Medical Officer 528.16k 1955 (70 years)
Mr. Ryan M. Confer M.S. President, CEO, CFO & Director 1982 (43 years)
Dr. Suzanne Thornton-Jones Ph.D. Senior Vice President of Regulatory Affairs & Quality
Dr. Jack A. Roth F.A.C.S., M.D. Chairman of Scientific & Medical Advisory Board

Address: United States, Austin. TX, 3300 Bee Cave Road - open in Google maps, open in Yandex maps
Website: https://www.genprex.com